RecallDepth
Class II Terminated

Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1), b) 30 count bottles (NDC: 68788-6382-3), c) 90 count bottles (NDC: 68788-6382-9), d) 100 count bottles (NDC: 68788-6382-0)

Company
Preferred Pharmaceuticals, Inc.
Recall Initiated
January 7, 2020
Posted
January 29, 2020
Recall Number
D-0797-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
39,172 tablets
Firm Location
Anaheim, CA, United States

Reason for Recall

CGMP Deviations: Presence of NDMA impurity detected in product.

Distribution

Distribution to physicians in the following states: AL, AZ, CA, FL, GA, IN, and SC

Lot / Code Info

Lot #: All lots within expiry

More recalls by Preferred Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls